The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to Treatment

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Bladder cancer (BCa) is a significant cause of morbidity with complex etiology.
• Recurrence is a major clinical challenge, managed with intravesical therapies like BCG.
• Current management faces limitations, including BCG supply and predicting recurrence risk.

Purpose of the Study:

• To review microRNAs (miRNAs) as potential biomarkers for predicting bladder cancer recurrence.
• To explore the role of miRNAs in predicting treatment response and resistance.
• To highlight the clinical utility of molecular biomarkers in bladder cancer management.

Main Methods:

• Literature review of studies investigating microRNAs in bladder cancer.
• Analysis of miRNA expression patterns related to BCa recurrence.
• Evaluation of miRNA roles in predicting response to intravesical therapies.

Main Results:

• Several microRNAs (miRNAs) have demonstrated potential as predictors of bladder cancer recurrence.
• MiRNAs show promise in identifying patients likely to respond or be resistant to treatments.
• Biomarker-driven approaches could personalize bladder cancer treatment strategies.

Conclusions:

• MicroRNAs represent a promising class of molecular biomarkers for bladder cancer.
• Utilizing miRNAs can aid in risk stratification and optimizing treatment selection for BCa patients.
• Further research into miRNAs can enhance clinical decision-making and improve patient outcomes.